Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant drug therapy: associated risks.

R Amrein1, S R Allen, D Vranesic

  • 1Department of PKF/TN, F. Hoffmann-La Roche & Co., Ltd., Basle, Switzerland.

Journal of Neural Transmission. Supplementum
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust modeling of material flows to end-uses under uncertainty: UK wood flows and material efficiency opportunities.

Journal of industrial ecology·2026
Same author

The relationship between processes and outcomes for injured older adults: a study of a statewide trauma system.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015
Same author

Penetrating torso injuries in older adults: increased mortality likely due to "failure to rescue".

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015
Same author

Initial venous lactate levels in patients with isolated penetrating extremity trauma: a retrospective cohort study.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015
Same author

Cardiotonic steroids induce anti-angiogenic and anti-proliferative profiles in first trimester extravillous cytotrophoblast cells.

Placenta·2014
Same author

Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2011
Same journal

Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.

Journal of neural transmission. Supplementum·2010
Same journal

A diet for dopaminergic neurons?

Journal of neural transmission. Supplementum·2010
Same journal

Immunization as treatment for Parkinson's disease.

Journal of neural transmission. Supplementum·2010
Same journal

Gene therapy for Parkinson's disease.

Journal of neural transmission. Supplementum·2010
Same journal

Stem cells and cell replacement therapy for Parkinson's disease.

Journal of neural transmission. Supplementum·2010
Same journal

Neurogenesis in substantia nigra of parkinsonian brains?

Journal of neural transmission. Supplementum·2010
See all related articles

New reversible monoamine oxidase inhibitor (MAOI) antidepressants like moclobemide offer improved safety and tolerance. These antidepressants are effective and safer in overdose compared to older classes, reducing the need for strict dietary restrictions.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Drug Safety

Background:

  • Antidepressant medications, including tricyclic (TCA), second-generation, and monoamine oxidase inhibitor (MAOI) classes, carry inherent risks.
  • Traditional MAOIs require strict dietary restrictions due to the risk of pressor responses with tyramine-containing foods.
  • Antidepressant safety in overdose and speed of onset are critical factors, especially considering suicide risk.

Purpose of the Study:

  • To discuss the risks associated with different classes of antidepressants.
  • To evaluate the safety and tolerance profile of moclobemide, a new reversible MAOI.
  • To compare moclobemide's efficacy, tolerance, and safety against other antidepressants.

Main Methods:

  • Review of risks associated with tricyclic (TCA), second-generation antidepressants, and monoamine oxidase inhibitors (MAOIs).

Related Experiment Videos

  • Focus on moclobemide, a reversible and preferential MAOI, examining its pharmacological properties and clinical implications.
  • Comparison of safety profiles, including liver toxicity, pressor response risk, side effects, and overdose safety, with other antidepressants.

    • Main Results:

    • Moclobemide, a benzamide derivative, selectively inhibits the A-form of monoamine oxidase.
    • Moclobemide demonstrates no liver toxicity and a very low risk of pressor response, negating the need for strict dietary adherence.
    • Moclobemide exhibits a low incidence of side effects, including anticholinergic effects, and has shown no deaths from overdose, similar to toloxatone.

    Conclusions:

    • Moclobemide offers efficacy comparable to other antidepressants.
    • Moclobemide is significantly superior in terms of tolerance and safety compared to existing antidepressant options.
    • The safety profile of moclobemide, particularly its reduced risk in overdose and lack of dietary restrictions, makes it a favorable treatment option.